UPDATE: Gilead Reports Preclinical Data By: Benzinga via Benzinga February 25, 2015 at 15:29 PM EST Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a preclinical study conducted in collaboration with researchers at ... Read More >> Related Stocks: Gilead Sciences